Ligand-induced membrane trafficking of the anaplastic lymphoma kinase (ALK) was studied using a chimeric receptor in which the extracellular and transmembrane domain of ALK was substituted for the corresponding regions of epidermal growth factor receptor (EGFR). Wild-type EGFR, EGFR/ALK and an EGFR/ALK kinase negative mutant were independently expressed in mouse NR6 fibroblasts. The capacity of EGFR/ALK to mediate [ 125 I]-EGF internalization, receptor degradation and downregulation, which has never been previously described, was assayed. The rate of [ 125 I]-EGF-induced internalization mediated by the cytoplasmic domain of ALK was reduced several fold compared with the wildtype EGFR. The low rate of EGF internalization promoted by EGFR/ALK correlated with an impaired degradation and downregulation of the receptor and indicate that ALK is not subject to traditional mechanisms used to regulate receptor tyrosine kinase function. Accordingly, ALK-activated intracellular domain does not associate in vivo with c-cbl and does not undergo ligand-mediated ubiquitination. The current study provides new insight into the function and regulation of ALK suggesting that the relative long membrane residence of activated ALK might confers a more potent and prolonged signaling activity. Indeed NR6-EGFR/ALK cells exhibited a B3-fold increase in a maximal mitogenic response than NR6-EGFR.
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Introduction
Growth factors bind to and activate the kinase domain of cell surface receptor tyrosine kinases (RTKs), which propagate the ligand-encoded signal across the plasma membrane and translate it into a cellular response. The complete understanding of the cell physiology mediated by the activation of cell surface receptors relies not only in the identification of downstream effectors but also in the regulation of receptors membrane trafficking, which controls the location of specific protein-protein interactions and the duration of the signal (Kholodenko, 2002) . Indeed, both initiation and termination of signal transmission depend on regulated movement of multiple components through vesicle compartments. Accumulating evidences have shown that ligand-induced endocytosis plays a dual role in receptor signaling: apart from its function as a biophysical mechanisms for attenuating the signal, endocytosis of RTKs is also implicated in the selective distribution of the activated receptors in the proper intracellular location to allow the interaction with specific downstream effector molecules (Di Fiore and De Camilli, 2001; Wiley and Burke, 2001) .
The mechanism of ligand-induced receptor internalization and downregulation has been extensively described for the epidermal growth factor receptor (EGFR) and subsequently confirmed in a wide variety of RTKs (Sorkin and Waters, 1993) . However, it has been shown that this phenomenon is not a general property of RTKs and indeed substantial differences in ligand-induced receptor trafficking exist also between member of the same receptor family (Baulida et al., 1996; Pinkas-Karmarski et al., 1996) . It is generally accepted that differences and/or alterations in receptors intracellular trafficking contribute to the potency of mitogenic and transforming activity and therefore are an important component of altered signal transduction in cancer (Di Fiore and Gill, 1999; Ceresa and Schmid, 2000; Waterman and Yarden, 2001 ). This idea is based on the correlation between low rates of EGFR internalization and cell transformation (Huang et al., 1997) and is supported by the observation that v-cbl transform cells at least in part by shunting EGFR back to the cell surface (Levkowitz et al., 1998) .
The ALK proto-oncogene encodes a receptor-type tyrosine kinase, which belongs to the insulin receptor superfamily (Iwahara et al., 1997; Morris et al., 1997) . The ligand for ALK has been recently identified as pleiotrophin (Stoica et al., 2001) . The oncogenic activity of ALK was initially associated with the chromosomal translocation t(2;5)(p23;q35) found in a high proportion of anaplastic large cells lymphomas (ALCLs). This translocation results in the expression of an oncoprotein in which the N-terminal region of the nuclear protein nucleophosmin (NPM) is fused to the intracellular domain of ALK (Morris et al., 1994) . Eight variant ALK fusion proteins have been recently characterized (Hernandez et al., 1999; Lamant et al., 1999; Ma et al., 2000; Touriol et al., 2000; Trinei et al., 2000; Tort et al., 2001) . In each case, the intracellular domain of ALK, which encompasses the tyrosine kinase activity, is fused to the N-terminus of an activating gene that determines an unscheduled expression and constitutive activation of ALK. Some ALK oncoproteins have been detected only in ALCLs, some others have been found only in nonhematopoietic neoplasms such as inflammatory myofibroblastic tumors, and some are present in both types of malignancy (Morris, 2001) .
In addition, a growing body of evidences indicates that ALK is expressed in a significant portion of human cancer cell lines, suggesting a potentially wider role for ALK products in the genesis of neoplastic processes. Indeed, recent studies indicate a direct casual link between overexpression of wild-type ALK and cellular transformation (Weber et al., 2000; Stoica et al., 2001; Piccinini et al., 2002) . In agreement with that, Miyake et al. (2002) reported gene amplification of ALK in different neuroblastoma cells.
A number of cytoplasmic signaling proteins have been shown to be physically associated with activated ALK (Fujimoto et al., 1996; Bishof et al., 1997; Stoica et al., 2001) although only a few have been shown to be strictly specific (Bai et al., 1998 (Bai et al., , 2000 Souttou et al., 2001; Slupianek et al., 2001; Piccinini et al., 2002) .
Despite studies concerning ALK-associated downstream effectors are in expansion, the endocytic trafficking of this RTK is at the moment completely undefined. Using a chimeric receptor containing the EGFR extracellular domain and ALK cytoplasmic domain (EGFR/ALK), we have functionally characterized the ability of ALK to undergo ligand-induced internalization, downregulation and degradation.
Results

Expression of EGFR and EGFR/ALK chimera in mouse fibroblasts
Expression vectors for wild-type EGFR and the EGFR/ ALK chimera have been previously described (Piccinini et al., 2002) . In addition, we engineered an EGFR/ALK kinase negative mutant (EGFR/ALK-KN) in which the nucleotide-binding lysine residue at position 1150 (numbered as specified in Morris et al., 1997) has been exchanged for an arginine residue (see Materials and methods). Mouse NR6 fibroblasts cells were independently transfected with each of the described constructs (schematically represented in Figure 1 ). Since NR6 cells Western blot analysis of the stable transfectants revealed the expression of each receptor in NR6 cells . Various transfectants were selected that express either moderate (1-2 Â 10 5 receptor/cell) or high (2-3 Â 10 6 receptor/cell) levels of surface receptors. We have previously described the biochemical characteristics and biological activities of the chimeric EGFR/ ALK receptors expressed in NIH 3T3 cells (Piccinini et al., 2002 Analysis of the tyrosine kinase activity revealed that both EGFR and EGFR/ALK receptors responded to the addition of EGF with increased levels of receptor autophosphorylation and cellular protein phosphorylation ( Figure 2 ) as previously reported in NIH-3T3 cells (Piccinini et al., 2002) . The loss of tyrosine kinase activity by the EGFR/ALK-KN mutant was indicated by its failure to react with antibodies to phosphotyrosine in immunoblot analysis (Figure 2 ).
Internalization of chimeric ALK receptors
To compare the rate of endocytosis of bound ligand, cells were briefly exposed to [ ]EGF from the acid-extractable (surface-bound) to the acidresistant (internalized) pool was determined as described in Materials and methods.
EGF endocytosis is a saturable process and has a maximal rate when low number of receptors are occupied by EGF (Wiley, 1988; Lund et al., 1990; ; therefore, internalization experiments were performed with [ 125 I]-EGF concentration ranging from 0.5 to 2 ng/ml so that fewer than 20.000 surface receptors were occupied during the assay.
We have initially analysed the internalization of [ Figure 5 ). In the absence of EGF, the half-lives of EGFR/ALK and EGFR/ALK-KN receptors (data not shown) were similar to that of the EGFR; however, the addition of EGF had no effect on the rate of degradation of EGFR/ALK (Figure 5a and b) .
The net result of ligand-induced receptor internalization and degradation is a decrease in the number of functional receptors on the cell surface, a phenomenon known as receptor downregulation. To substantiate the [ 125 I]-EGF internalization and degradation rate observed in NR6-EGFR/ALK cells, we measured the ability of Internalization of EGFR/ALK chimera M Serresi et al EGF to promote downregulation of the EGFR/ALK chimera.
NR6 transfectants were incubated at 371C with a saturating concentration of unlabeled EGF (100 ng/ml) for various periods of time and subsequently washed to remove unbound ligand-and surface-associated EGF. The number of residual binding sites at the cell surface was then measured by incubating the cells at 41C with a saturating concentration of [ 125 I]-EGF. As shown in Figure 6 , EGFR was rapidly downregulated by approximately 75%, while downregulation of the EGFR/ALK chimera was approximately 24%. Therefore, the reduced rates of internalization and degradation of EGFR/ALK correlates with an impaired downregulation of the chimera. Downregulation is also influenced by the relative rates of receptor recycling. It is unlikely that the observed differences were the consequence of a more rapid EGF recycling in NR6-EGFR/ALK cells. In fact, it is known that when measurements are made over short periods of time, differences between apparent rates of internalization (ratio of internalized and surface ligand) reflect differences between specific internalization rates (Wiley et al., 1991; Sorkin et al., 1992 Analysis of EGFR/ALK and native ALK internalization by immunofluorescence staining Ligand-mediated internalization of the EGFR/ALK chimera was also examined through fluorescence microscopy using the EGFR-specific antibody Ab-1, which reacts with the external domain of EGFR. To this end, NR6-EGFR and NR6-EGFR/ALK were exposed to saturating concentration of EGF (100 ng/ml) for 15 min at 371C and processed for immunostaining. These experiments indicated that both in absence and in presence of EGF, the EGFR/ALK chimera was localized at the plasma membrane and no endosome association was detected: similar results were obtained when the anti-ALK-c monoclonal antibody was used for immunostaining (Figure 7d and e) . On the contrary, under the same experimental conditions, EGF induced the appearance of brightly stained vescicles in the cell periphery and perinuclear region in NR6-EGFR cells, indicating the presence of a significant portion of EGFR in endosome (Figure 7a and b) .
Although the ALK cytoplasmic domain is tyrosine phosphorylated in response to EGF binding and does transduce biological responses such as mitogenesis and transforming activity, it may be argued that receptor trafficking functions are not accurately reproduced in the chimeric molecule. Therefore, in the same experiments we have analysed NR6 cells transfected with the native ALK molecule (NR6-ALK), which is a highaffinity receptor for the recently identified pleiotrophin (Stoica et al., 2001) . As shown in Figure 7i , after 15 min incubation with 2 ng/ml pleiotrophin, ALK was localized only in the plasma membrane and showed the same distribution pattern observed in absence of stimulation (Figure 7g ). Similar results were obtained when NR6-ALK cells were incubated with higher concentrations of pleiotrophin (up to 8 ng/ml) (data not shown), although in NR6-ALK cells stimulation with 2 ng/ml pleiotrophin was sufficient to induce rapid ALK tyrosine phosphorylation.
Receptors association to c-cbl and subsequent receptors polyubiquitination The results described above indicate that ALK does not undergo ligand-mediated rapid internalization: this could be related to an unefficient interaction of ALK with the endocytic apparatus. Different studies have shown that c-cbl is required for ligand-dependent ubiquitination of EGFR, a modification that target the protein to the lysosome degradative pathway. We have, therefore, determined whether impaired ALK internalization is paralleled by deficient association with c-cbl. Lysates obtained from untreated and EGF-stimulated NR6-EGFR and NR6-EGFR/ALK cells were immunoprecipitated with anti-c-cbl antibodies. Immunoblotting with anti-EGFR (Figure 8a , left panel) demonstrated in vivo association of c-cbl with activated EGFR, as previously reported (Galisteo et al., 1995) . Under the same experimental conditions, no c-cbl association of EGFR/ALK was revealed, despite similar amount of c-cbl were present in the immunocomplexes (Figure 8, right panel) . Accordingly, no ubiquitin immunoreactivity was evident in EGF-stimulated EGFR/ALK immunocomplexes (Figure 8b ).
Mitogenic potency of EGFR/ALK
The system analysed above offers the opportunity to ask whether a receptor that does not undergo ligandinduced internalization and downregulation may be more mitogenic than a receptor, which is rapidly downregulated, particularly at low growth factor concentrations. Therefore, we have used NR6 cells expressing either EGFR or EGFR/ALK receptors to assay the mitogenicity of increasing concentrations of EGF. For these experiments, we used two markerselected mass populations (NR6-EGFR and NR6-EGFR/ALK) displaying a comparable number of EGF-binding sites. Figure 9 shows a typical EGF-dose experiment observed in these cell lines. NR6-EGFR/ ALK cells were more sensitive to EGF, as evidenced by an B3-fold increase in maximal mitogenic response as compared to NR6-EGFR, despite similar levels of EGFbinding sites and affinities. In addition, NR6-EGFR/ ALK cells also were more sensitive to EGF, as demonstrated by higher levels of mitogenic stimulation, than were NR6-EGFR cells, particularly at low EGF doses. Similar results have been previously obtained in NIH-3T3 cells (Piccinini et al., 2002) . Based on these data, we conclude that the lack of a rapid ligandinduced endocytosis of EGFR/ALK might be involved in the enhanced biological activity of ALK.
Discussion
Regulated trafficking of the EGFR has been extensively investigated over several decades and probably represents the best-characterized receptor trafficking system. It is well established that EGF binding to its receptor results in downregulation of EGFR: this downregulation is attributed to the rapid internalization of the activated receptors via clathrin-coated pits followed by the efficient sorting of the internalized receptors to the lysosome degradation pathway (Sorkin and Waters, 1993) . This mechanism has been demonstrated for other growth factor receptors and for a long time the concept of rapid ligand-mediated endocytosis and downregulation of growth factor receptors has been improperly considered a general rule. Indeed, new and interesting concepts in our understanding of receptors trafficking have been provided in the last years. First, it is now evident that RTKs might present completely different endocytic properties and therefore follow distinct fate after ligand stimulation Baulida et al., 1996; Pandi et al., 1997; Waterman et al., 1998) . Furthermore, it is becoming clear that endocytosis and signal transduction are two processes tightly connected, regulating one other in both a positive and negative manner (Ceresa and Schmid, 2000; Di Fiore and De Camilli, 2001; Wiley and Burke, 2001 ). Consequently, analysis of receptors trafficking is an important Our previous study has demonstrated that the EGFR/ ALK chimera respond to EGF and is significantly more active in inducing transformation and DNA synthesis than the wild-type EGFR when either are expressed at similar levels in NIH 3T3 cells. Comparative analysis of the biochemical pathways implicated in the transduction of mitogenic signals showed that EGFR/ALK chimera was much more efficient than EGFR to induce PI3-kinase activity, suggesting that the stronger mitogenic potency of ALK is partially related to its more efficient coupling with the PI3-K pathway (Piccinini et al., 2002) .
The mechanisms controlling membrane trafficking of ALK have never been investigated. To gain insight into the activated ALK endocytic properties, we have comparatively analysed the rate of ligand-induced internalization of EGFR/ALK chimeric receptors and wild-type EGFRs. EGFR/ALK internalized EGF at a rate that was several fold lower than the rate of ligand internalization by wild-type EGFR. Our data also reveal a minimal extent of downregulation of EGFR/ALK. Receptors immunoprecipitation analysis on [
35 S]-labeled cells demonstrates a relative long membrane residence of the EGFR/ALK chimera, which did not substantially differ in presence of EGF. Therefore, the reduced rate of internalization of EGFR/ALK also resulted in an impaired degradation and downregulation of the receptor. It is unlike that the observed differences are the consequence of a rapid EGFR/ALK recycling, since recovery of intact [ Studies addressing the importance of the tyrosine kinase activity in endocytosis have been performed on different RTKs. It is generally accepted that receptor tyrosine kinase activity is required for cellular trafficking: for that reason, we have also included in our study a kinase-defective EGFR/ALK mutant. The extent of [ 125 I]EGF internalization was slightly lower with the mutationally inactivated kinase. However, considering the slow internalization rate observed for the EGFR/ ALK, employment of such a mutant does not add further information to our present knowledge.
Despite a large amount of phenomenological data, the molecular details of the mechanisms controlling ligandinduced endocytosis of RTKs are still confused and not fully understood. It is generally accepted that receptor recruitment into plasma membrane clathrin-coated pits requires 'endocytic recognition sequences' that allow specific interaction with coated pit components. Several mutagenesis studies have been used to map these critical amino-acid sequences in the RTKs cytoplasmic tail: identified endocytic signals are represented by the sequences NPXY and YXX+ (where + represents an amino acid with a bulky hydrophobic group and X stands for any amino acid) or by a di-leucine motif (Di Fiore and Gill, 1999) . Under this assumption, lack of a rapid, ligand-induced endocytosis of EGFR/ALK should indicate an inefficient interaction of the ALK cytoplasmic domain with the cellular endocytic apparatus. However, different sequences in the cytoplasmic domain of ALK fulfill the criteria for the described putative internalization codes (NPXY: ALK residues 1093-1096, NPNY and residues 1504-1507, NPTY; YXX+: ALK residues 1401-1404, YGPL plus several di-leucine motifs), suggesting that the presence of these putative endocytic codes are not sufficient to promote ligand-mediated receptor internalization. Indeed, it has been shown that mutations of the FYRAL sequence within the cytoplasmic domain of EGFR, which abrogate its interaction with the adaptor protein AP-2, do not significantly affect EGF-induced receptor internalization (Nesterov et al., 1995; Sorkin et al., 1996) . In addition, although the erbB-2 intracellular domain contains putative internalization sequences at approximately the same relative position of the EGFR, an EGFR/erbB-2 chimeric receptor displays very low rate of ligand-induced internalization, downregulation and degradation and does not associate with AP-2 Baulida et al., 1996) . Possibly additional unidentified sequences are involved. Alternatively, a much more complex scenario should be considered, involving not only the presence of correct information for capture in clathrin-coated pits, but also proper signals that allow the receptor to reach them. In line with this point of view, it has been shown that in quiescent fibroblasts a large fraction of EGFRs are concentrated in caveolae but rapidly move out of this membrane domain in response to EGF (Mineo et al., 1999) . In addition, it has been demonstrated that all the EGFR mutants that are endocytosis impaired also are unable to leave caveolae in response to ligand stimulation. Based on their observations, the authors of this work propose an endocytosis three-step model which involves (1) exit from caveolae; (2) migration in the bulk plasma membrane; (3) capture by coated pits (Mineo et al., 1999) . Under this possibility, an inefficient movement of ALK out of caveolae may be related to its impaired internalization, despite the presence of functionally relevant endocytic codes in its cytoplasmic domain.
The current study provide new insight into the function and regulation of ALK. Future research into the function of endocytic accessory factors and signaling proteins will likely reveal additional connections between ALK endocytosis and signaling, and improve our information on the oncogenic property of this receptor.
Materials and methods
Eukaryotic expression vectors and site-directed mutagenesis
The engineering of the expression vectors LTR-EGFR 5 M and LTR-EGFR/ALK have been previously described (Lonardo et al., 1990; Piccinini et al., 2002) . To generate the EGFR/ALK kinase-negative mutant, a 2.2 kbp BamHIBamHI fragment from the LTR-EGFR/ALK plasmid was cloned into M13mp18 phage RF DNA. Oligonucleotideprimed site-directed mutagenesis was performed on phage ssDNA template according to the method of Kunkel (1985) , by mutagenizing the AAG (Lys) codon at position 1150 of the ALK open reading frame to AGG (Arg). After modification of the desired sequence, the BamHIBamHI fragment was cloned back into the vector. The presence of the mutation in the expression vector was confirmed by DNA sequencing in both strands. The LTR-ALK expression vector was obtained by cloning the entire human ALK coding sequence (ATCC) into the LTR-2 expression vector (Di Fiore et al., 1987) .
Cell culture and transfection assays NR6 and NIH-3T3 mouse fibroblasts were maintained in Dulbecco's modified Eagle's medium (D-MEM) containing 10% fetal bovine serum (FBS) (Invitrogen) and transfected with circular plasmid DNA according to the calcium phosphate precipitation technique. Mass cell populations containing the LTR-based vectors were selected for their ability to form colonies in a medium containing mycophenolic acid, taking advantage of the presence of the selectable marker Ecogpt (Mulligan and Berg, 1981) .
EGF-binding assays
Scatchard analysis were performed as described (Piccinini et al., 2002) The number of receptors per cell and their dissociation constants (K d ) for EGF were determined from Scatchard plots. Analysis of the binding was performed with the LIGAND software. ]EGF. Finally, the cells were solubilized with 1 N sodium hydroxide to quantitate internalized radioactivity. The ratio of internalized and surface radioactivity was plotted against time and the specific rate constant for internalization (K e ) was calculated as linear regression coefficient. Nonspecific binding was measured for each time point in the presence of 100-fold molar excess of unlabeled EGF (Upstate Biotechnology Inc.).
Internalization and receptor recycling assays
To monitor receptor recycling, cells were rinsed with ice-cold binding buffer and incubated with [ 
Receptor downregulation
To monitor receptor downregulation, cells were incubated for various times (0-120 min) with or without EGF (100 ng/ml) in binding medium at 371C, rinsed with cold binding medium, and surface-bound EGF was removed by incubating cells with ice-cold 0.2 M sodium acetate buffer (pH 4.5) containing 0.5 M NaCl for 2 min and 20 s followed by two rinses with binding medium. This acid wash procedure did not affect the binding properties of receptors. The number of binding sites on the cell surface was then determined by incubating the cells 100 ng/ml [ 125 I]EGF at 41C for 2 h. The amount of surface-bound [ 125 I]EGF corresponding to the number of surface receptors was then determined by the acid wash (pH 2.8) as described for the internalization experiments.
Receptor degradation
To study EGF receptor turnover, cells were metabolically labeled with [
35 S]TransLabel (ICN Biochemical) overnight at 371C in methionine-and cysteine-free medium containing 1% calf serum and 60 mCi [ 35 S]TransLabel/ml. Cells were then washed three times with D-MEM to remove unincorporated radiolabeled amino acids. The monolayers were then incubated at 371C with or without 200 ng/ml EGF in binding medium for the indicated period before lysis and immunoprecipitation with the anti-EGFR Ab-1 antibody as described below. The amount of radioactivity in the protein bands corresponding to each receptor was quantitated using a Phosphoimager apparatus (Molecular Dynamics).
Immunofluorescence
Cells were grown on glass coverslips to subconfluence. Following serum starvation for 24 h, cells were either mocktreated or treated with EGF (Upstate Biotechnology Inc.) or pleiotrophin (Sigma) at the indicated concentrations for 15 min at 371C. Cells were fixed for 10 min in 4% paraformaldehyde in PBS and thereafter permeabilized by incubation for 15 min in phosphate-buffered saline (PBS) supplemented with 0.1 and 0.5% BSA. After blocking with 1% BSA in PBS, cells were incubated at room temperature in the presence of specific antibodies (anti-EGFR Ab-1 or anti-ALK-c) followed by donkey anti-mouse IgG conjugated with FITC (1 : 50 in PBS). Nuclear counterstaining was performed by incubating coverslips for 15 min at 251C with 4'6'-diamidino-2-phenylindole (Sigma). Samples were analysed and photographed using an Olympus AX70 fluorescence microscope.
Protein analysis
Cells treatment and lysis was performed as previously described (Piccinini et al., 2002) . For immunoprecipitation procedures, cellular lysates were incubated with the indicated antibody for at least 2 h at 41C under gentle rotation and immunocomplexes were recovered on Protein-G bound to Sepharose beads (Zymed). After several washes with buffer containing 0.1% Triton X-100, 20 mM HEPES, 10% glycerol and 150 mM NaCl immunocomplexes were resuspended in Laemmli buffer and boiled. Lysates or immunocomplexes were separated by SDS-PAGE, transferred onto nitrocellulose filters and immunoblotted according to previously published procedures (Piccinini et al., 2002) . Bound proteins were visualized with [ 125 I]labeled anti-mouse-IgG (0.2 mCi/ml) (Amersham Pharmacia Biotech) or by enhanced chemiluminescence (Amersham Pharmacia Biotech).
The monoclonal antibody recognizing the intracellular domain of ALK (ALK-c) was kindly provided by Professor B Falini (Institute of Haematology, University of Perugia, Italy) and Professor PG Pelicci (European Institute of Oncology, Milan, Italy) (Falini et al., 1998) . Ab-1, the monoclonal antibody directed against the extracellular domain of EGFR, was purchased from Calbiochem. The rabbit anti-peptide polyclonal sera recognizing the EGFR carboxylterminal tail (residues 985-996) was previously described (Piccinini et al., 2002) . Other antibodies used were the antiphosphotyrosine (anti-pTyr) monoclonal antibody (Upstate Biotechnology), the affinity purified polyclonal C-15 anti c-cbl antibodies (Santa Cruz Biotechnology) and the anti-vinculin monoclonal antibody (clone hVIN-1) (Sigma). Receptor polyubiquitination was analysed according to Kassenbrock et al. (2002) using the monoconal anti-ubiquitin antibody MMS-258 (BABCO). Briefly, cells were starved of growth factors for 18 hours and then stimulated for 10 minutes at 371C with 100 ng/ml EGF. N-ethylmaleimide (5 mM) was added to the lysing buffer. Immunocomplexes, obtained by incubating total cellular proteins with Ab-1 were resolved on a 7.5% SDS-PAGE and electrotransfered to an Immobilon-P membrane (Millipore).
Mitogenic assay
The [ 3 H]-incorporation assay was performed as described previously (Piccinini et al., 2002) . Data are expressed as a mitogenic index calculated as the fraction of stimulation obtained in the presence of EGF with respect to the stimulation obtained in the presence of nonsaturating concentrations of an optimal mitogen (1% FBS). The mitogenic index was calculated as follows: [(EGF cpmÀbackground cpm)/(1% serum cpmÀbackground cpm)] Â 100.
Abbreviations ALCL, anaplastic large cell lymphoma; ALK, anaplastic lymphoma kinase; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; PTyr, phosphotyrosine; RTK, receptor tyrosine kinase.
